ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1228

Spine Immobilization and Neurological Complications in Vertebral Osteomyelitis: Results from a Multicenter Prospective Observational Study

Géraldine Bart1, Guillaume Coiffier2, Oriane Merot3, Emmanuel Hoppe4, Marion Couderc5, Denis Mulleman6, Gregoire Cormier7, Jean Marc Ziza8 and Benoit Le Goff1, 1Rheumatology, Nantes University Hospital, Nantes, France, 2Rheumatology, Rennes University Hospital, Rennes, France, 3rheumatology unit, Saint Nazaire Hospital, Saint Nazaire, France, 4Angers University Hospital, Angers, France, 5Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, 6Université François-Rabelais de Tours, CNRS 7292, Tours, France, 7Service de Rhumatologie, CHD de la Roche-Sur-Yon, La Roche-Sur-Yon, France, 8Medecine Interne-Rhumatologie, Groupe hospitalier Diaconesses-Croix-Saint-Simon, Paris, France

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Infection, Neurologic involvement, osteomyelitis and spine involvement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Infection-related Rheumatic Disease Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: In a previous work, we showed that neurological complication can occur in up to 40% of patients with vertebral osteomyelitis (VO). Bed rest and spine immobilization are usually prescribed to prevent those complications. There is currently no consensus about the best immobilization protocol to follow in VO. Objectives of our work were to assess the prescription of spine immobilization for VO and its effect of neurological complications.

Methods: A prospective study was performed in 10 centers. All patients with native VO were included and followed prospectively: neurological complications, imaging findings, type and duration of immobilization were reported and patients were divided in two groups: “Immobilization” or “No Immobilization”, regarding if they had a prescription of spine bracing or not. We present here the data of our study after 6 months of follow-up.

Results:

To date, 102 patients were included: 72 in the “Immobilization” group, and 30 in the “No Immobilization” group. Median duration of symptoms before diagnosis was 27 days, IQR (11-40).

Thirty-six percent of the patients (n=37) had an abnormal neurological exam at baseline: 23.5% (n=24) had minor neurological signs (sensory loss or radiculopathy), and 12.7% (n=13) had major neurological signs (motor deficit or cauda equine syndrome). During hospital stay, 4 patients developed major neurological signs (median 5 days after diagnosis) and 5 patients developed minor neurological signs (median 6 days after diagnosis). Half of the patients with abnormal neurological exam at baseline had a normal neurological examination at 6 months.

Median duration of bed rest was 9 days (IQR 7-18). In the “Immobilization” group (n=72), median duration of spine bracing was 8 weeks, IQR (6-12) and it was rigid bracing in 90% of cases. Main characteristics of the 2 groups are described in Table 1. They were no significant differences in age, associated diseases, or pathogen. Only one patient in the “No Immobilization” Group developed a paraplegia during follow-up, and the reason of the absence of immobilization was unclear. All patients with cervical involvement had a prescription of spine immobilization, whereas only half of the patients with lumbar involvement were immobilized. There were significantly less thoracic spine involvement in the “Immobilization” group. There were no differences in terms of neurological complications during follow-up between the two groups.

Immobilization

n= 72 (%)

No immobilization

n=30 (%)

p

Demographical characteristics

Age, years (standard deviation)

65 (+/- 15)

72 (+/- 14)

NS

Male

51 (70.8)

17 (56.6)

0,18

Diabetes

14 (19.4)

8 (26.6)

0,4

Obesity (BMI>30kg/M2)

17 (23.6)

8 (26.6)

0,7

Level of vertebraes involved

Multifocal

11 (15.3)

9 (30)

0,09

Lumbar

37 (51.4)

16 (53.3)

0,8

Thoracic

18 (25)

14 (46.6)

0,03

Cervical

13 (18.1)

0

NS

Pathogen

Staphylococcus aureus

22 (30.5)

12 (40)

0,3

Neurological state

Major neurological sign at baseline

7 (9.7)

5 (16.6)

0,3

Minor neurological sign at baseline

20 (27.7)

4 (13.3)

0,11

Major neurological sign occurring during follow up

3 (4.2)

1 (3.3)

0,8

Minor neurological sign occurring during follow up

5 (6.9)

0

NS

Conclusion:

Neurological complications occurred in 36% of our patients. Interestingly, 30% of our patients were not immobilized. None of them had cervical involvement and neurological outcome was favorable for 95% of “Not Immobilized” patients.


Disclosure: G. Bart, None; G. Coiffier, None; O. Merot, None; E. Hoppe, None; M. Couderc, None; D. Mulleman, None; G. Cormier, None; J. M. Ziza, None; B. Le Goff, None.

To cite this abstract in AMA style:

Bart G, Coiffier G, Merot O, Hoppe E, Couderc M, Mulleman D, Cormier G, Ziza JM, Le Goff B. Spine Immobilization and Neurological Complications in Vertebral Osteomyelitis: Results from a Multicenter Prospective Observational Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/spine-immobilization-and-neurological-complications-in-vertebral-osteomyelitis-results-from-a-multicenter-prospective-observational-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/spine-immobilization-and-neurological-complications-in-vertebral-osteomyelitis-results-from-a-multicenter-prospective-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology